Related by context. All words. (Click for frequent words.) 74 HCV Hepatitis C 69 CYT# potent vascular disrupting 68 AzaSite TM 68 hepatitis C HCV 68 LymphoStat B belimumab 68 nucleotide analogue 68 vaginal candidiasis 67 acyclovir Lauriad R 67 VivaGel ™ 67 toenail onychomycosis 67 FOLOTYN ® 67 Hepatitis C Virus HCV 67 HCV polymerase 67 Amgen Neulasta R 67 novel VDA molecule 67 systemic fungal infections 67 P#X# antagonist 66 Alferon LDO 66 Entry Inhibitor 66 Daclizumab 66 oral prodrug 66 Golimumab 66 Vicriviroc 65 relapsing remitting MS RRMS 65 kidney urologic 65 budesonide foam 65 Achieves Primary Endpoint 65 trastuzumab DM1 T DM1 65 oncolytic virus therapies 65 Omacetaxine 65 Shigatoxin producing E. coli 65 Phase 1a clinical 65 ALN TTR 65 OncoVex 65 investigational oral hepatitis C 65 LymphoStat B TM 65 Etravirine 65 miconazole Lauriad ® 65 nucleotide analog 65 proprietary radiolabeled monoclonal 65 Uvidem 65 IMiDs ® compound 65 Personalized Immunotherapy 65 Initiates Enrollment 65 PANVAC VF 65 phase IIb study 65 investigational therapies 65 Aganocide 65 oropharyngeal candidiasis OPC 65 Hepatitis C virus HCV 65 latent tuberculosis infection 65 delivers fluocinolone acetonide FA 65 acetonide FA 65 R5 tropic 65 Allovectin 7 65 oropharyngeal candidiasis 65 Evoltra ® 65 Potelligent Technology 65 PHX# 65 Phase IIb clinical trials 65 lumiliximab 65 novel oral anticoagulant 64 hepatitis C virus HCV 64 Cytomegalovirus CMV 64 Iluvien ® 64 LungAlert TM 64 Severe Sepsis 64 Prodarsan R 64 apricitabine ATC 64 invasive candidiasis 64 SIMPONI TM 64 terlipressin 64 Pivotal Study 64 lintuzumab SGN 64 Nexavar sorafenib 64 phase IIa 64 methylnaltrexone bromide 64 Hedgehog Pathway Inhibitor 64 Pseudomonas lung 64 thetreatment 64 CDAD Clostridium difficile 64 Phase Ib IIa 64 SPRYCEL ® 64 Immunotherapeutic 64 virus HCV protease inhibitor 64 phase IIb trial 64 Hepatitis B HBV 64 reslizumab 64 Phase 2b Clinical Trial 64 treatment naïve genotype 64 Fabry Disease 64 neovascular diseases 64 Pafuramidine 64 Phase #/#a 64 Phase IIIb clinical 64 histamine dihydrochloride 64 Cimzia TM 64 treatment naive genotype 64 Vertex hepatitis C 64 Hepatitis C Virus 64 Phase IIa trials 64 Respiratory Syncytial Virus RSV 64 recombinant biopharmaceutical 64 non nucleoside inhibitor 64 Clevudine 64 Recombinant interferon alpha 64 HTS assay 64 NS5b 64 dirucotide MBP# 64 Initiates Phase II 64 PNP inhibitor 64 cSSSIs 64 STELARA TM 64 Nasdaq RDEA 64 chronic HBV 64 A1PI 64 Vidaza R 64 Aflibercept 64 p# biomarker 64 human C1 inhibitor 64 Hemopurifier 64 catheter occlusion 64 Archexin 64 Veronate 64 hypereosinophilic syndrome 64 sargramostim 64 either acutely decompensated 64 Spiegelmer ® 64 aldehyde dehydrogenase ALDH2 deficiency 64 Completes Patient Enrollment 63 Alferon N 63 virus HCV infection 63 elotuzumab 63 OHR/AVR# 63 receptor tyrosine kinase inhibitor 63 JAK2 Inhibitor 63 Therapeutic Vaccine 63 Rilonacept 63 pediatric Crohn disease 63 naive HCV 63 Shigamabs ® 63 SEBIVO 63 MAXY alpha 63 nosocomial pneumonia 63 Bayer HealthCare Onyx Pharmaceuticals 63 HCV NS5B polymerase 63 Solazed TM 63 Naive Patients 63 Phase Ib clinical 63 Mipomersen 63 LEUKINE 63 tramiprosate Alzhemed TM 63 HuMax TAC 63 Hedgehog antagonist 63 diarrhea predominant irritable 63 Silodosin 63 Phase III Pivotal 63 Aryplase 63 Acute Decompensated Heart Failure 63 SinuNase TM 63 Dacogen decitabine 63 mSEPT9 63 Aurexis 63 CRMD# 63 OMNARIS Nasal Spray 63 Virulizin ® 63 evaluating tivozanib 63 Initiate Clinical Trial 63 AFREZZA TM 63 ancrod 63 Phase IIb Clinical Trial 63 MKC# MT 63 VivaGel TM 63 Hepatitis B Hepatitis C 63 ALN TTR# 63 Initiates Clinical 63 vaginally administered lidocaine 63 Celgosivir 63 cytomegalovirus infection 63 glucokinase activator 63 Roche PEGASYS R 63 mertansine 63 R#/MEM 63 GVAX ® 63 tiapamil 63 CCR5 inhibitor 63 ChronVac C R 63 Meets Primary Endpoint 63 Pivotal Phase III 63 Dalbavancin 63 psoriasis Crohn disease 63 OraQuick ® 63 Nasdaq VRTX 63 metastatic neuroendocrine tumors 63 Phase #b/#a clinical 63 phase III isavuconazole 63 apoptosis inducer 63 OMNARIS HFA 63 null responder HCV 63 TRANSDUR ™ 63 candidate XP# 63 CIMZIA TM certolizumab pegol 63 TransVax TM 63 recurrent glioblastoma multiforme 63 chronic HCV 63 protease inhibitors PIs 63 orally inhaled migraine 63 CCR5 antagonist 63 Cardiotoxicity 63 Arcalyst 63 adalimumab Humira 63 esophageal candidiasis 63 ZFP Therapeutics 63 phase IIa clinical 63 reduce serum phosphate 63 Factor VIIa 63 ALN PCS 63 multicenter Phase II 63 volociximab 63 HEPLISAV TM 63 Pertuzumab 63 THR beta agonist 63 TLR9 agonist IMO 63 Phase Ib II 63 visit www.genenews.com 63 antiretroviral naïve 62 CD# CEA 62 Phase IIb Trial 62 HCD# [002] 62 dasatinib Sprycel 62 JAK2 inhibitor 62 refractory gout 62 Hepatocellular Carcinoma HCC 62 severe gastroparesis 62 CHAMPION PCI 62 brand ciclesonide HFA 62 targeted radiotherapeutic 62 Onalta ™ 62 G#DT 62 Telbivudine 62 ALVESCO ® 62 DermaVir Patch 62 Cx# [002] 62 Annamycin 62 MAGE A3 ASCI 62 Alvesco R 62 Nucleic Acid Detection Immunoassay 62 Prednisporin TM 62 ulimorelin 62 Cloretazine ® 62 Tigecycline 62 Vitrasert R 62 Zemiva TM 62 CMV vaccine 62 Zenvia Phase III 62 AEG# 62 Amgen Neulasta ® 62 Bucindolol 62 refractory chronic lymphocytic 62 relapsed MM 62 Velcade bortezomib 62 Xcytrin R 62 dose intramuscular 62 SinuNase ™ 62 psoriasis rheumatoid arthritis 62 chemotherapy induced neutropenia 62 molecular imaging radiopharmaceutical 62 Myocet 62 AERx ® 62 SynCon ™ DNA 62 Elagolix 62 investigational hepatitis C 62 Kit CD# positive 62 BARACLUDE R 62 Xanafide 62 Bosutinib 62 HuLuc# 62 aerosolized AAT 62 Civacir 62 hoFH 62 serogroup B 62 CCR5 inhibitors 62 Ecallantide 62 EVIZON ™ 62 rilonacept 62 Pfizer Selzentry 62 chronic HCV infection 62 Bazedoxifene 62 VIR# 62 non nucleoside HCV 62 PDX pralatrexate 62 including eniluracil ADH 62 Hsp# Inhibitor 62 Safinamide 62 EVIZON TM 62 Fx #A 62 ospemifene 62 ZFP Therapeutic 62 UPLYSO 62 phase Ib clinical 62 assessing T DM1 62 LUMINATE 62 omacetaxine mepesuccinate 62 Polymerase Inhibitor 62 ceftazidime 62 ALN HPN 62 ALVESCO R 62 prokinetic agent 62 inhibit replication 62 candidates Azedra TM 62 ANTEGREN 62 HIV coinfected 62 Atripla combines 62 XL# anticancer compounds 62 oral proteasome inhibitor 62 lexidronam injection 62 hepatitis B HBV 62 Bendamustine 62 Gamunex C 62 HepeX B 62 labial herpes 62 Behcet uveitis 62 cardio renal 62 SPL# Gel vaginal microbicide 62 antibody MAb 62 Actimmune ® 62 vapreotide acetate 62 DEB# 62 MYCAMINE 62 Virologic 62 opioid induced constipation OIC 62 Simulect 62 Phase IIIb study 62 Combination REOLYSIN R 62 CCR5 tropic HIV 62 Diabetic Macular Edema DME 62 telomerase therapeutic 62 HQK 62 Hepatitis B virus HBV 62 anti botulism antibody 62 HCV polymerase inhibitor 62 Pegloticase 62 Xelox 62 Initiates Phase 2b 62 CEQ# 62 Viread tenofovir disoproxil fumarate 62 AIMM trial 62 AMD# [002] 62 APEX PD 62 metaglidasen 62 FDA APPROVES 62 gastro intestinal inflammation 62 topically applied SEPA 62 Glufosfamide 62 SNT MC# 62 Frozen Shoulder Syndrome 62 IMC #B 62 Boceprevir 62 Associated Diarrhea 62 PrevOnco 62 hepatitis C viral infection 62 ELADUR ™ 62 Eculizumab 62 ORENCIA R 62 Fibrillex TM 61 metastatic malignant 61 Telatinib 61 intravenous acetaminophen 61 Sebivo 61 disease CDAD 61 Nanobody R 61 lucinactant 61 novel L DOS# 61 daptomycin 61 NEUGENE 61 GLP toxicology studies 61 lenalidomide Revlimid R 61 GW# [003] 61 successfully commercialize Iluvien 61 DNAwithPap TM Test 61 investigational integrase inhibitor 61 nephropathic cystinosis 61 Nasdaq OPTR 61 TYZEKA 61 Biologic License Application BLA 61 REMOXY ® 61 Muraglitazar 61 Glatiramer Acetate 61 naive HCV genotype 61 Quinamed 61 include Alferon N 61 Gleevec imatinib mesylate 61 sorafenib tablets 61 forodesine 61 intranasal formulation 61 CCR9 antagonist 61 investigational humanized monoclonal antibody 61 HCV protease inhibitors 61 StaphVAX R 61 REGN# 61 Fludara ® 61 liposomal formulation 61 Cloretazine 61 Vion Pharmaceuticals 61 intra abdominal infections 61 trivalent seasonal influenza 61 cMET 61 ImmuKnow R 61 personalized cellular immunotherapy 61 PRN FDA Approves 61 rALLy clinical trial 61 decompensated liver disease 61 smoldering multiple myeloma 61 virus HCV 61 Ribavirin causes 61 nucleoside analog 61 vidofludimus 61 Cleviprex TM clevidipine 61 Ramoplanin 61 midstage trials 61 infectious diseases autoimmune diseases 61 HCV antiviral 61 Ketotransdel 61 oral FTY# 61 ABSSSI 61 Investigational Treatment 61 Troxatyl 61 PDE# inhibitors 61 enterococcal 61 OvaRex ® MAb 61 Augment ™ 61 Hepatitis C Viral 61 NNRTI resistant virus 61 Phase III Clinical Trial 61 drug ISA# 61 BrachySil TM 61 Finacea 61 M# rationally 61 Epratuzumab 61 novel therapeutic antibodies 61 Pyridorin 61 dasatinib Sprycel ® 61 REMUNE R 61 herpes zoster shingles 61 novel histone deacetylase 61 antibiotic resistant bacterial infections 61 relapsed multiple myeloma 61 Phase 1b clinical trials 61 Zingo TM 61 Sustiva efavirenz 61 Fludase 61 Pentacel R 61 Epstein Barr Virus EBV 61 etanercept Enbrel 61 next generation URAT1 61 IMiDs ® 61 Cardio Vascu Grow 61 ONCONASE R 61 Alinia 61 rheumatoid arthritis psoriatic arthritis 61 Paromomycin 61 protein tyrosine phosphatase 1B 61 Aurograb 61 Macrolide 61 vinorelbine tartrate 61 LHRH antagonists 61 Dyloject TM 61 paclitaxel Taxol ® 61 Selzentry maraviroc 61 Antibody Drug Conjugate 61 initiated Phase Ib 61 small molecule tyrosine 61 investigational protease inhibitor 61 POSIDUR TM 61 monoclonal antibody MAb 61 Dacogen injection 61 Ciclesonide 61 CB2 selective receptor agonist 61 aripiprazole Abilify 61 severe hypercholesterolemia 61 Certolizumab pegol 61 overactive bladder VANTAS R 61 Maribavir 61 miconazole Lauriad 61 Cimzia ® certolizumab pegol 61 Interferon beta 1b 61 Shigamabs R 61 platinum chemotherapeutic 61 Tezampanel 61 zanolimumab 61 Eraxis 61 Leukine ® 61 CONBRIZA 61 Aviptadil 61 Files IND 61 R sorafenib tablets 61 psoriatic arthritis PsA 61 Daptomycin 61 Alfacell proprietary ribonuclease 61 thalidomide Thalomid 61 IAP inhibitor 61 Receives Orphan Drug Designation 61 Inc. Amex SYI 61 PI3K/Akt pathway inhibitor 61 VitiGam 61 Plicera 61 Rheumatoid Arthritis RA 61 CCR5 tropic 61 INS# [001] 61 systemic juvenile idiopathic 61 Panzem R 61 MVA BN R 61 oral salmon calcitonin 61 combination antiretroviral therapy 61 Noxafil 61 Zenvia ™ 61 Liprotamase 61 Phase #b/#a trial 61 telaprevir VX 61 QNEXA ® 61 HBeAg negative 61 REMOXY R 61 Hepatitis B Virus 61 drug eluting coronary stent 61 Surfaxin LS 61 phase IIb clinical 61 histone deacetylase HDAC inhibitor 61 molecular diagnostic assay 61 OvaRex R 61 Rigel R# 61 cytomegalovirus CMV 61 IMA# 61 RNAi Therapeutic 61 SUTENT ® 61 de novo kidney transplant 61 Gets FDA Clearance 61 MT#/MEDI-# 61 NASH Huntington 61 generation purine nucleoside 61 Natalizumab 61 recombinant interferon 61 null responder 61 OTCBB PYTO 61 Vaccine Protects Against 61 Recurrent Glioblastoma 61 TB Vaccine 61 BCX# 61 E1 INT TM 61 liposomal ciprofloxacin 61 Chronic Hepatitis B 61 im peramivir 61 Moxifloxacin 61 EGS# 61 Proellex TM 61 Phase IIIb 61 investigational monoclonal antibody 61 Opterone R 61 TKM ApoB 61 TBC# 61 Onconase 61 clevudine 61 IV APAP 61 OnDose 61 treat chronic sinusitis 61 JAK inhibitor 61 immunotherapeutic vaccine 61 latent tuberculosis TB 61 TELINTRA 61 HCV protease inhibitor 61 Peginterferon alfa 2b 61 GI motility disorders 61 LAB CGRP 61 ribavirin RBV 61 HCV RESPOND 2 61 Aztreonam 61 REBETOL combination therapy 61 ® daptomycin 61 Exelixis XL# 61 OncoVEX GM CSF 61 ® natalizumab 61 ADP receptor antagonist 61 immune modulators 61 canakinumab 61 HCV Protease Inhibitor 61 JOULFERON 61 celgosivir 61 TTR amyloidosis 61 BARACLUDE ® 61 ILUVIEN ® 61 Valopicitabine 61 P aeruginosa 61 PREOS R 61 bardoxolone methyl 60 Oral Fluid 60 inflammatory autoimmune diseases 60 subcutaneous immunoglobulin 60 PGL# 60 Q#IR 60 include ColorectAlert TM 60 Temsirolimus 60 HuMax 60 PSMA ADC 60 Aganocide ® 60 CCX# 60 Interferon Alpha 60 Teplizumab 60 Manja Bouman CEO 60 Twinrix 60 TLK# 60 Tarvacin TM 60 multicenter Phase III 60 GALNS 60 recombinant adeno associated 60 CCR5 mAb 60 NDA Submission 60 RELISTOR ® 60 PF # [002] 60 Presents Positive Preclinical 60 ALN VSP Phase 60 neurogenic orthostatic hypotension 60 Raptiva R 60 Thiovir 60 POSIDUR TM ELADUR TM 60 IV Busulfex 60 Rheumatoid Arthritis Drug 60 protease inhibitor PI 60 Vaccine Candidate 60 Bicifadine 60 Phase Ib study 60 Ceflatonin R 60 proteasome inhibitor 60 Entereg TM 60 huN# DM1 60 Kepivance 60 Phase 2b Trial 60 Zorbtive TM 60 IL-#/# 60 DAS# [001] 60 trastuzumab emtansine T DM1 60 Trofex TM 60 ChimeriVax JE 60 Generx ™ 60 Actemra tocilizumab 60 Insegia 60 NovaBay Aganocide compounds 60 docetaxel Taxotere ® 60 RAPTIVA 60 Chlamydia trachomatis infection 60 ARIXTRA R 60 Hemopurifier ® 60 antisense inhibitors 60 faropenem 60 alpha1 antitrypsin deficiency 60 Amigal TM 60 Urocidin TM 60 Anidulafungin 60 hyperphenylalaninemia HPA due 60 r hGH 60 PrevOnco ™ 60 EP #R 60 HIV integrase inhibitors 60 Pivotal Phase 60 novel emulsion formulation 60 Oglemilast 60 Enzastaurin 60 Deforolimus 60 Tibotec BVBA 60 dacetuzumab 60 Phase 2b clinical trials 60 pneumocystis pneumonia PCP 60 CERVARIX 60 alfa 2a 60 Dupuytren Contracture 60 CD# monoclonal antibody 60 acute peripheral arterial 60 Cloretazine R 60 Tyzeka Sebivo 60 oral antiviral 60 Sprycel dasatinib 60 SUPPRELIN R LA 60 SIMPONI ® 60 Arranon 60 Solazed 60 protease inhibitor telaprevir 60 Demonstrates Significant 60 BAL# [002] 60 gastrointestinal stromal tumors GIST 60 TOCOSOL Camptothecin 60 NS5B polymerase 60 Shigamabs 60 Therapeutic Competitors Companies 60 Lymphocytic 60 rALLy trial 60 sJIA 60 SYN# 60 Dasatinib 60 riociguat 60 Albuferon TM 60 idiopathic thrombocytopenic purpura ITP 60 anthrax botulism typhoid 60 HuMax EGFr 60 MEK inhibitor 60 equine osteoarthritis 60 Soliris eculizumab 60 agonistic human 60 Genentech Rituxan 60 Kuvan TM sapropterin 60 REVIVE Diabetes 60 Tarceva TM 60 Exherin TM 60 Omalizumab 60 RhuDex ® 60 Phase #/#a trial 60 XmAb ® 60 visceral leishmaniasis VL 60 ROTATEQ 60 IMiDs R 60 Raptiva ® 60 post herpetic neuralgia PHN 60 relapsed leukemia 60 AcryMed Incorporated 60 Nipent R 60 Edurant 60 orthopoxvirus 60 acyclovir Lauriad ® 60 lomitapide 60 Fodosine 60 ketolide antibiotic 60 ThermoDox R 60 Ozarelix 60 Gleevec resistant 60 humanized therapeutic 60 TASKi2 60 HGS# 60 Dapagliflozin 60 Combivir Kivexa 60 XL# XL# 60 Phase #b/#a 60 pemetrexed Alimta 60 ano genital warts 60 evaluating mipomersen 60 HepC 60 Sudhir Agrawal D.Phil 60 myelodysplastic myeloproliferative diseases 60 Antitumor 60 Isentress raltegravir 60 ALGRX 60 YONDELIS 60 Systemic Delivery 60 Adjuvant Treatment 60 TRX1 60 PREVENAR 60 cutaneous T 60 NV1FGF 60 Tykerb lapatinib 60 DNAwithPap Test 60 Cethromycin 60 overactive bladder syndrome 60 Nasdaq HALO 60 Phase 2a Trial 60 midstage clinical 60 gastrin analogue TT 60 bortezomib Velcade 60 sapacitabine CYC# 60 immunological diseases 60 Degarelix 60 orally administered inhibitor 60 Crofelemer 60 Acute Radiation Syndrome ARS 60 STELARA ™ 60 cryptococcosis 60 SCIB1 60 relapsed refractory multiple myeloma 60 interferon ribavirin 60 Septin 9 60 albiglutide 60 UVIDEM 60 thiazolides 60 candidemia 60 introduced NEUGENE 60 Omigard 60 Neugene 60 Rotavirus Vaccine 60 COPEGUS R 60 Mycophenolate Mofetil 60 Diabetic Macular Edema 60 personalized immunotherapy 60 Unit Dose Budesonide 60 DEFLUX 60 MyVax R 60 neratinib 60 OncoVEX 60 osteolytic bone disease 60 brivanib 60 Bacteremia 60 Virulizin R 60 Phase III HEAT 60 MAXY VII 60 intravenous iv peramivir 60 gefitinib Iressa 60 LibiGel ® 60 nalbuphine ER 60 regorafenib 60 interferon alpha IFN 60 EVIZON TM squalamine lactate 60 LHRH receptor positive 60 Septin9 60 Cellegesic 60 fusion inhibitor 60 microbiological eradication 60 Vidaza ® 60 CRLX# 60 steroid refractory GvHD 60 Roche Xeloda 60 Prolongs Survival 60 ORENCIA ® 60 Nektar proprietary 60 Tesmilifene 60 immunotherapeutic approaches 60 R MSCRAMM 60 collagen vascular 60 Phase III Clinical Trials 60 AA Amyloidosis 60 MassARRAY R 60 Ganciclovir 60 delivery polymer matrix 60 Gilead Viread 60 AB OMXS BINV 60 Prodarsan ® 60 GED aPC 60 Augment TM 60 systemic RNAi therapeutic 60 essential thrombocythemia ET 60 valtorcitabine 60 pegylated interferon alpha 60 Glybera R 60 opioid induced bowel dysfunction 60 Vitaxin 60 dirucotide 60 Onalta 60 PEGylated interferon 60 Kamada AAT 60 topical anti infective 60 Entereg R 60 APTIVUS R 60 BEMA TM Fentanyl 60 investigational pharmacologically unique 59 Monoclonal antibody 59 StemEx R 59 concurrent ITP 59 MCSP respectively 59 ionotropic glutamate receptor antagonists 59 chronic eosinophilic leukemia 59 Pegasys plus Copegus 59 Nanobody 59 radezolid 59 Serostim ® 59 HFA MDI 59 Antibacterials 59 Initiate Phase 59 mitogen activated ERK kinase 59 Tipranavir 59 Motavizumab 59 MRSAid TM 59 Cancidas 59 cannabinor 59 Aplidin 59 CTAP# Capsules 59 JZP 59 immune globulin intravenous 59 Entecavir 59 itraconazole Sporanox 59 PDE4 inhibitor 59 Pruvel 59 erlotinib Tarceva ® 59 Zalypsis 59 ongoing Phase 1b 59 e antigen HBeAg 59 Patients Treated With 59 IIb clinical trial 59 Mycobacterium tuberculosis TB 59 Ceftaroline 59 biologic DMARD 59 Shows Promise Against 59 Cytomegalovirus 59 MyVax ® 59 SCH # 59 ASX PGL 59 PRT# 59 TMC# C# 59 Neulasta R 59 Adenoviral 59 HepaGam B 59 baminercept 59 ocular inflammatory 59 ToGA 59 Xyfid TM 59 Ocrelizumab 59 Chronic Hepatitis C 59 commercialize CorMedix drug 59 Helicobacter pylori H. pylori 59 Pazopanib 59 artemisinin derivative 59 Glypromate 59 Mycograb 59 MenACWY 59 TPI ASM8 59 systemic invasive fungal 59 INSTI TM 59 Alzhemed TM 59 Sanvar R 59 AKT inhibitor 59 HCV SPRINT 59 RELOVAIR ™ 59 torezolid phosphate 59 Phase 1b clinical 59 rxRNA 59 Microplasmin 59 Androxal TM 59 Telavancin 59 Deferiprone 59 CCR5 receptor antagonist 59 bardoxolone 59 Fresenius Biotech 59 Ridaforolimus 59 PEGylated anti 59 PROSTVAC TM 59 cancer neuroendocrine tumor 59 Cinquil 59 Plenaxis TM 59 zoledronic acid Reclast 59 BRIM2 59 GTC recombinant human 59 ALN RSV# 59 candidate REP# 59 NS5A 59 PROGENSA R 59 IL# PE#QQR 59 immuno inflammatory diseases 59 Femring ® 59 rALLy 59 Iluvien TM 59 therapeutic monoclonal antibody 59 Drug Eluting Stent System 59 alvespimycin 59 Ophena TM 59 constipation OIC 59 SIR Spheres 59 anti CD3 monoclonal 59 rheumatoid arthritis thrombocytopenia 59 Loramyc R 59 Preotact R 59 BCR ABL inhibitor 59 CINTREDEKIN BESUDOTOX 59 refractory metastatic 59 oral nucleoside analogue 59 Abbott RealTime 59 Saquinavir 59 WILEX 59 therapeutic monoclonal antibodies 59 atazanavir Reyataz 59 % uracil topical 59 ATL# [001] 59 Tasimelteon 59 pregnancy bacterial vaginosis 59 visilizumab 59 GlaxoSmithKline Plc Relenza 59 pradefovir 59 investigational hepatitis B 59 recurrent genital herpes 59 VERSANT 59 OvaRex 59 NeutroSpec TM 59 THALOMID 59 ChronVac C 59 antisense drug 59 registrational 59 HIV Integrase 59 Kivexa 59 Oral NKTR 59 Xeloda ® 59 RSD# oral 59 TASKi3 59 include Healive 59 FluCide 59 Pivotal Trial 59 intradermal delivery 59 purinergic receptors P#X# 59 Vitro Diagnostic IVD 59 Pirfenidone 59 basiliximab 59 ofatumumab HuMax CD# 59 INCB# [001] 59 oral methylnaltrexone 59 PLK1 SNALP 59 MOVIPREP R 59 ocrelizumab 59 bacterial respiratory infections 59 tezampanel NGX#